At the root of Lyv, there is the patient’s reality, from women suffering from endometriosis. Women, who had to go... View Article
Author Archives for Adeline Chauvigné
New member | Lyv Healthcare
2 May 2024At the root of Lyv, there is the patient’s reality, from women suffering from endometriosis. Women, who had to go... View Article
XAV-19: end of EUROXAV clinical trial and positive trends for the XENOTHERA antibody
Nantes-based biotech XENOTHERA, which develops innovative antibodies in several therapeutic areas, has developed XAV-19, an anti-COVID treatment based on its... View Article
XAV-19: end of EUROXAV clinical trial and positive trends for the XENOTHERA antibody
2 May 2024Nantes-based biotech XENOTHERA, which develops innovative antibodies in several therapeutic areas, has developed XAV-19, an anti-COVID treatment based on its... View Article
New member | HPR Solutions
HPR solutions develops and sales soft mobility solutions called the Urbaner range: 3 electrically assisted tricycles, one of which is... View Article
New member | HPR Solutions
2 May 2024HPR solutions develops and sales soft mobility solutions called the Urbaner range: 3 electrically assisted tricycles, one of which is... View Article
New member | Où suis-je
Où suis-je is an innovative start-up created by Denis TROCH and Dominique MAGUER in March 2022, which offers an application... View Article
New member | Où suis-je
2 May 2024Où suis-je is an innovative start-up created by Denis TROCH and Dominique MAGUER in March 2022, which offers an application... View Article
New member | MedSynApps
Founded in France in 2017, MedSynApps provides a full range of consulting and development services for the medical and enterprise... View Article
New member | MedSynApps
2 May 2024Founded in France in 2017, MedSynApps provides a full range of consulting and development services for the medical and enterprise... View Article
AbolerIS Pharma benefits from the REACT-EU program
AbolerIS Pharma is a pre-clinical stage biotech company specialized in the development of innovative immunomodulators for the treatment of transplant... View Article
AbolerIS Pharma benefits from the REACT-EU program
2 May 2024AbolerIS Pharma is a pre-clinical stage biotech company specialized in the development of innovative immunomodulators for the treatment of transplant... View Article
Parean Biotechnologies and Keyrus Life Science announce their alliance to accelerate innovation in biometry, bioinformatics and biostatistics, in the EU and North America
Parean Biotechnologies and Keyrus Life Science and will join their expertise in data science and technologies to meet the most critical... View Article
Parean Biotechnologies and Keyrus Life Science announce their alliance to accelerate innovation in biometry, bioinformatics and biostatistics, in the EU and North America
2 May 2024Parean Biotechnologies and Keyrus Life Science and will join their expertise in data science and technologies to meet the most critical... View Article
BIOSENCY signs strategic partnership with ResMed
New major step in BIOSENCY’s development. The startup specialized in remote patient monitoring medical devices dedicated to chronic cardio-respiratory pathologies... View Article
BIOSENCY signs strategic partnership with ResMed
2 May 2024New major step in BIOSENCY’s development. The startup specialized in remote patient monitoring medical devices dedicated to chronic cardio-respiratory pathologies... View Article
ABYS® MEDICAL winner of the i-Nov innovation competition
After being elected winner of the i-Lab 2019 edition, the company Abys® Medical, based in La Rochelle (France), is now... View Article
ABYS® MEDICAL winner of the i-Nov innovation competition
2 May 2024After being elected winner of the i-Lab 2019 edition, the company Abys® Medical, based in La Rochelle (France), is now... View Article
OSE Immunotherapeutics appoints Nicolas Poirier as Chief Executive Officer
OSE Immunotherapeutics is pleased to announce the appointment of Dr. Nicolas Poirier as new Chief Executive Officer. This appointment follows... View Article
OSE Immunotherapeutics appoints Nicolas Poirier as Chief Executive Officer
2 May 2024OSE Immunotherapeutics is pleased to announce the appointment of Dr. Nicolas Poirier as new Chief Executive Officer. This appointment follows... View Article